Ledger.Open graph →
SEC Form D · filed January 3, 2025

RAPT Therapeutics, Inc

Offering
$150.0M
Sold
$150.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Dirk F. Brockstedt · South San Francisco, CAExecWilliam J. Rieflin · South San Francisco, CADirectorWilliam F. Ho · South San Francisco, CAExecLori V. Lyons-Williams · South San Francisco, CADirectorBrian Wong · South San Francisco, CAExec · DirectorLinda J. Kozick · South San Francisco, CADirectorMichael F. Giordano · South San Francisco, CADirectorWendye J. Robbins · South San Francisco, CADirectorRodney J. Young · South San Francisco, CAExecMary Ann V. Gray · South San Francisco, CADirectorJoshua Malouf · Goleta, CAExecChristopher Savoie · Boston, MADirectorGuilherme Peres · Goleta, CADirectorClark Golestani · Boston, MAExec · DirectorEmily Hanson · Goleta, CAExecAmber D. Ramsey · GRAND CAYMAN, Cayman IslandsDirectorGary Linford · Grand Cayman, Cayman IslandsDirectorTodd A. Rowley · GREENWICH, CTDirectorMark Cupta · Boston, MADirectorMatthew Peltier · Brentwood, TNExecMichael D'Angelo · Tucson, AZExecTerry Esser · Tucson, AZExecJennifer Henderson · Fort Collins, CODirectorMichael B. Lazar · Greenwich, CTDirectorFranklin J. Collins Iv · Greenwich, CTDirectorNasrin Thierer · Chicago, ILExec · DirectorDennis Eulau · New York, NYExecWilliam Hausberg · ST. LOUIS, MODirectorJim Fox · ST. LOUIS, MODirectorMike Duran · ST. LOUIS, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗